|Table of Contents|

HES1 expression and its correlation with prognosis in breast cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 06
Page:
872-875
Research Field:
Publishing date:

Info

Title:
HES1 expression and its correlation with prognosis in breast cancer
Author(s):
Li XiaoyingCao YuJin Feng
Department of Breast Surgery,The First Affiliated Hospital of China Medical University,Liaoning Shenyang 110001,China.
Keywords:
HES1breast cancerprognosis
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2018.06.014
Abstract:
Objective:To examine the expression pattern and biological roles of HES1 in breast cancers and to explore the relationship of HES1 and prognosis in breast cancers.Methods:We examined HES1 expression in 115 breast cancer tissues using immunohistochemistry and Western blot analyses.Correlation between HES1 expression and prognosis in breast cancers was analyzed by Kaplan-Meier analysis.Results:A significant association was found between HES1 overexpression and advanced TNM stage(P=0.003),nodal metastasis(P=0.043),negative estrogen receptor expression(P=0.001),negative progesterone receptor expression(P=0.042) and triple-negative status(P=0.001).Positive HES1 expression was associated with lower progression-free survival(P=0.005) and overall survival(P=0.001) in breast cancer patients.Conclusion:HES1 may be an independent prognostic factor for breast cancers.

References:

[1] Siegel R,Naishadham D,Jemal A.Cancer statistics[J].CA Cancer J Clin,2012,62:10-29.
[2]Ahn S,Cho J,Sung J,et al.The prognostic significance of tumor-associated stroma in invasive breast carcinoma[J].Tumour Biol,2012,33:1573-1580.
[3]Limame R,de Beeck KO,Van Laere S,et al.Expression profiling of migrated and invade breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer[J].Oncoscience,2014,1:69-81.
[4] Ishibashi M,Moriyoshi K,Sasai Y,et al.Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system[J].EMBO J,1994,13:1799-1805.
[5] Liu ZH,Dai XM,Du B,et al.Hes1:A key role in stemness,metastasis and multidrug resistance[J].Cancer Biol Ther,2015,16(3):353-359.
[6]Sang L,Roberts JM,Coller HA.Hijacking HES1:How tumors co-opt the anti-differentiation strategies of quiescent cells[J].Trends Mol Med,2010,16:17-26.
[7] Tian C,Zheng G,Cao Z,et al.Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment[J].Cell Cycle,2013,12:322-331.
[8] Iso T,Kedes L,Hamamori Y.HES and HERP families:Multiple effectors of the notch signaling pathway[J].J Cell Physiol,2003,194:237-255.
[9] Ingram WJ,McCue KI,Tran TH,et al.Sonic hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signaling[J].Oncogene,2008,27:1489-1500.
[10]Stockhausen MT,Sjolund J,Axelson H.Regulation of the notch target gene hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells[J].Exp Cell Res,2005,310:218-228.
[11]Curry CL,Reed LL,Golde TE,et al.Gamma secretase inhibitor blocks notch activation and induces apoptosis in Kaposi's sarcoma tumor cells[J].Oncogene,2005,24:6333-6344.
[12]Rani A,Greenlaw R,Smith RA,et al.HES1 in immunity and cancer[J].Cytokine Growth Factor Rev,2016,30:113-117.
[13]Davis RL,Turner DL.Vertebrate hairy and enhancer of split related proteins:Transcriptional repressors regulating cellular differentiation and embryonic patterning[J].Oncogene,2001,20:8342-8357.
[14]Paroush Z,Finley RL Jr,Kidd T,et al.Groucho is required for drosophila neurogenesis,segmentation,and sex determination and interacts directly with hairy-related bHLH proteins[J].Cell,1994,79:805-815.
[15]Zhang Y,Xu W,Guo H,et al.NOTCH1 signaling regulates self-renewal and platinum chemoresistance of cancer stem-like cells in human non-small cell lung cancer[J].Cancer Res,2017,77(11):3082-3091.
[16]Goto N,Ueo T,Fukuda A,et al.Distinct roles of HES1 in normal stem cells and tumor stem-like cells of the intestine[J].Cancer Res,2017,77(13):3442-3454.
[17]Wang X,Fu Y,Chen X,et al.The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance:A retrospective clinical study[J].J Cancer Res Clin Oncol,2010,136:989-996.
[18]Cenciarelli C,Marei HE,Zonfrillo M,et al.The interference of Notch1 target Hes1 affects cell growth,differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets[J].Oncotarget,2017,8(11):17873-17886.
[19]Hidalgo-Sastre A,Brodylo RL,Lubeseder-Martellato C,et al.Hes1 controls exocrine cell plasticity and restricts development of pancreatic ductal adenocarcinoma in a mouse model[J].Am J Pathol,2016,186(11):2934-2944.
[20]Wang SC,Lin XL,Wang HY,et al.HES1 triggers epithelial-mesenchymal transition(EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway[J].Oncotarget,2015,6:36713-36730.
[21]Yu He,Zhou Ping,Li Dan,et al.Expression and prognostic value of Notch3 and HES1 in non-small cell lung cancer[J].Modern Oncology,2017,25(07):1043-1047.
[22]Gao F,Zhang YQ,Wang SC,et al.Hes1 is involved inthe self-renewal and tumourigenicity of stem-like cancercells in colon cancer[J].Sci Rep,2014,4:3963.
[23]Yuan R,Ke J,Sun L,et al.HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer[J].Clin Exp Metastasis,2015,32(2):169-179.
[24]Orzechowska M,Jedroszka D,Bednarek AK.Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer[J].Oncotarget,2017,8(4):6013-6032.
[25]Bennani-Baiti IM,Aryee DN,Ban J,et al.Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma[J].J Pathol,2011,225:353-363.
[26]Wall DS,Mears AJ,McNeill B,et al.Progenitor cell proliferation in the retina is dependent on notch-independent sonic hedgehog/Hes1 activity[J].J Cell Biol,2009,184:101-112.

Memo

Memo:
-
Last Update: 2018-01-29